Experimental drug aims to slow lung scarring in IPF
NCT ID NCT05389215
First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This phase 2 trial tests whether an experimental drug called DWN12088 can safely slow the decline in lung function for people with idiopathic pulmonary fibrosis (IPF), a progressive lung-scarring disease. About 102 adults aged 40 and older with stable IPF will be randomly assigned to receive either DWN12088 or a placebo, and neither they nor their doctors will know which they receive. The study measures changes in breathing tests, lung scans, and exercise capacity over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- an experimental drug called DWN12088
- What this could lead to
- If successful, DWN12088 could offer a new treatment option to slow lung function decline in people with idiopathic pulmonary fibrosis.
- What could go wrong
- This is a mid-stage trial with only 102 participants, so results may not confirm benefit. The drug could also cause side effects not yet seen in earlier studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ajou University Hospital
Hwaseong-si, Gyeonggido, 16499, South Korea
-
Asan Medical Center
Seoul, Seoul, 05505, South Korea
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Baylor Scott & White Research Institute
Dallas, Texas, 75204, United States
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Dignity Health Norton Thoracic Institute
Phoenix, Arizona, 85013, United States
-
Duke University Medical Center
Durham, North Carolina, 27705, United States
-
Inje University Busan Paik Hospital
Busan, Busan, 47392, South Korea
-
Legacy Research Institute
Portland, Oregon, 97232, United States
-
Lowcountry Lung and Critical Care
Charleston, South Carolina, 29406, United States
-
Loyola University Medical Center (LUMC)
Maywood, Illinois, 60153, United States
-
Myongji Hospital
Goyang-si, Gyeonggi-do, 10475, South Korea
-
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
-
Pulmonary Associates, PA
Mesa, Arizona, 85206-1346, United States
-
Pulmonix Research, LLC
Greensboro, North Carolina, 27403, United States
-
Samsung Medical Center
Seoul, Seoul, 06351, South Korea
-
Seoul National University Hospital
Seoul, Seoul, 03080, South Korea
-
Severance Hospital, Yonsei University Health System
Seoul, Seoul, 03722, South Korea
-
Soon Chun Hyang University Hospital Bucheon
Bucheon-si, Gyeonggido, 14584, South Korea
-
The Catholic University of Korea, Bucheon St. Mary's Hospital
Bucheon-si, Gyeonggi-do, 14647, South Korea
-
The Lung Research Center, LLC
Chesterfield, Missouri, 63017, United States
-
The U.S. Department of Veterans Affairs
Charleston, South Carolina, 29401, United States
-
The University of California San Francisco
San Francisco, California, 94143, United States
-
The University of Texas Health San Antonio Medical Arts & Research Center
San Antonio, Texas, 78229-3901, United States
-
The University of Texas Southwestern Medical Center
Dallas, Texas, 75390-9020, United States
-
Tufts Medical Center
Boston, Massachusetts, 02111, United States
-
Ulsan University Hospital
Ulsan, Ulsan, 44033, South Korea
-
University of Kansas Medical Center Research Institute, Inc
Kansas City, Kansas, 66160, United States
-
University of Michigan Health System
Michigan Center, Michigan, 48109, United States
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- What makes someone stop a lung fibrosis drug? a study asks patients directly
- A smarter way to track lung disease? new platform aims to personalize COPD and IPF care
- AI outruns radiologists in detecting early lung scarring
- AI-Designed drug targets scarred lungs in major trial
- Can scans replace breathing tests to monitor lung scarring?
- New drug candidate SCB0020160 enters first human safety tests